BioAtla enlists first patient in Phase 1/2 BA3011-001 Clinical Trial for CAB-AXL-ADC Therapeutic Read more
CMIC Holdings and Median Technologies venture into agreement ensuring Clinical Trial Services Read more
Longeveron commenced treatment of first Left Heart Syndrome patient using mesenchymal stem cell therapy Read more